"

New England Journal of Medicine – biological biomedical sciences Journal Guide for Researchers

Why Researchers Choose New England Journal of Medicine for High-Impact Publications

The New England Journal of Medicine stands as a cornerstone in the field of biological biomedical sciences, renowned for its rigorous standards and influential role in shaping medical knowledge worldwide. Established in 1812, this weekly publication has evolved into a beacon for clinicians, researchers, and policymakers, delivering cutting-edge studies on clinical trials, epidemiological insights, and therapeutic advancements. Its commitment to evidence-based medicine ensures that every article undergoes meticulous peer review, fostering trust among the global scientific community.

Researchers gravitate toward the New England Journal of Medicine for its ability to amplify their work's reach. With a circulation exceeding 500,000 and digital access serving millions, publications here drive citations and career progression. The journal's scope encompasses a broad spectrum of topics, from oncology and cardiology to infectious diseases and public health, making it ideal for interdisciplinary studies. Its impact factor of 96.2, one of the highest in medicine, underscores its prestige, often cited in guidelines and policy decisions.

Submitting to the New England Journal of Medicine demands excellence, but the rewards are substantial. Accepted papers gain immediate visibility through online first publication and multimedia supplements, enhancing their educational value. The journal's editorial team, led by experts in various subspecialties, provides constructive feedback that refines research quality. For early-career scientists, a publication here can open doors to funding, collaborations, and leadership roles in academia.

Beyond original research, the New England Journal of Medicine features editorials, reviews, and case records that contextualize findings, aiding practical application. Its hybrid model balances subscription access with open options, ensuring wide availability without compromising sustainability. As biological biomedical sciences advance rapidly, this journal remains pivotal in bridging laboratory discoveries to bedside implementations.

To explore academic opportunities that align with such high-caliber research, visit our biomedical research positions page for the latest faculty and postdoctoral openings.

Overview & History

The New England Journal of Medicine traces its origins to 1812, founded by a group of Boston physicians amid the War of 1812. Initially titled the New England Journal of Medicine and Surgery, it merged with other publications to become the authoritative voice in American medicine. Over two centuries, it has chronicled pivotal moments, from the discovery of insulin to COVID-19 vaccine trials.

Published by the Massachusetts Medical Society, the journal transitioned to weekly issues in 1928, expanding its influence. Key milestones include introducing randomized controlled trials in the 1950s and embracing digital formats in the 1990s. Today, it publishes over 600 original articles annually, maintaining a legacy of innovation while adapting to open access trends.

Its historical archives, accessible via the official site, offer invaluable resources for meta-analyses and historical reviews in biological biomedical sciences.

Scope and Disciplines Covered

The New England Journal of Medicine covers the full breadth of clinical and translational research in biological biomedical sciences. It prioritizes studies with direct implications for patient care, including etiology, diagnosis, treatment, and prevention of diseases.

DisciplineDescription
Internal MedicineComprehensive coverage of adult diseases, from hypertension to rheumatology.
Clinical TrialsPhase I-IV studies on therapeutics and interventions.
Infectious DiseasesEmerging pathogens, vaccines, and antimicrobial resistance.
OncologyCancer biology, immunotherapy, and precision medicine.
CardiologyCardiovascular risk factors, procedures, and outcomes.
Public HealthEpidemiology, health policy, and global health equity.

This multidisciplinary approach ensures relevance across subspecialties, appealing to a diverse readership.

Key Journal Metrics

MetricValueSource
Impact Factor (2023)96.2Clarivate Journal Citation Reports
5-Year Impact Factor93.8Clarivate JCR
CiteScore176.2Scopus
h-Index1,023Scopus
Acceptance RateApproximately 6%Publisher data
Time to First Decision4-6 weeksJournal guidelines

These metrics highlight the journal's selectivity and influence, guiding researchers in evaluating publication venues.

Indexing and Abstracting

The New England Journal of Medicine is indexed in major databases, ensuring discoverability. Key services include PubMed/MEDLINE for biomedical literature, Web of Science for citation tracking, and Scopus for comprehensive analytics. It is also listed in Embase, Cochrane Library, and DOAJ for open access content.

This extensive coverage amplifies research visibility and facilitates interdisciplinary connections.

Publication Model and Fees

As a hybrid journal, the New England Journal of Medicine operates on a subscription model for standard access, with an open access option via NEJMoa. There are no mandatory article processing charges (APCs) for subscription publications; however, authors electing open access pay $5,000-$6,500, depending on length.

Waivers are available for low-income countries per Sherpa/RoMEO policies. Copyright is retained by authors under Creative Commons licenses for OA articles, promoting reuse while protecting integrity.

Submission Process and Guidelines

Manuscripts are submitted exclusively online via the journal's portal at NEJM Author Center. Guidelines emphasize originality, ethical compliance (ICMJE standards), and concise reporting (e.g., 2,000-3,500 words for originals).

Steps include: 1) Pre-submission inquiry; 2) Upload via Editorial Manager; 3) Peer review (double-blind); 4) Revisions; 5) Acceptance and proofreading. Conflicts of interest must be disclosed, and clinical trials registered (e.g., ClinicalTrials.gov).

For detailed protocols, consult the official author instructions.

Editorial Board Highlights

The editorial board comprises luminaries in biological biomedical sciences, chaired by Editor-in-Chief Eric J. Rubin, MD, PhD, a pathologist with expertise in infectious diseases. Deputy editors oversee sections like clinical medicine and global health, drawing from Harvard Medical School and international institutions.

Highlights include: Dr. Caren G. Solomon (endocrinology), Dr. Lindsey R. Baden (oncology), and international advisors from Europe and Asia, ensuring diverse perspectives.

Why Publish in New England Journal of Medicine?

Publishing here elevates research profiles, with articles averaging 500+ citations in the first year. It accelerates clinical adoption, influences guidelines (e.g., WHO, CDC), and boosts grant success rates. For biological biomedical sciences scholars, it's a hallmark of excellence, distinguishing CVs in competitive job markets.

Multimedia integration, such as videos and infographics, enhances engagement, while rapid online publication minimizes delays.

Comparison with Similar Journals

JournalImpact FactorFocusAcceptance Rate
New England Journal of Medicine96.2Clinical & translational medicine~6%
The Lancet168.9Global health & policy~5%
JAMA120.7General medicine & evidence-based practice~10%
BMJ93.3Clinical research & education~12%
Annals of Internal Medicine51.4Internal medicine subspecialties~15%

This comparison positions the New England Journal of Medicine as a top-tier choice for high-impact clinical work.

Researcher Tips for Successful Submission

To track academic timelines, explore our academic calendar for deadlines and events.

Additionally, connect with peers via Rate My Professor for insights on faculty experiences. For more resources, see PhD programs in biomedical sciences, postdoc opportunities in medicine, tenure-track faculty jobs, research grants database, conference listings in medicine, journal submission tips, career advice for academia, publishing resources, peer review training, open access journals guide, impact factor explained, and academic networking events.

Frequently Asked Questions about New England Journal of Medicine

πŸ“ˆWhat is the current impact factor of the New England Journal of Medicine?

The 2023 impact factor is 96.2, according to Clarivate Journal Citation Reports, making it a top venue in biological biomedical sciences. For more on metrics, check our impact factor explained guide.

πŸ”What is the acceptance rate for submissions?

The acceptance rate is approximately 6%, reflecting high selectivity. Aspiring authors can prepare by reviewing journal submission tips on our site.

πŸ’°Does the New England Journal of Medicine charge APCs or have an open access policy?

It follows a hybrid model with no APC for subscription articles, but open access incurs $5,000-$6,500. Details align with Sherpa/RoMEO. Learn more via our open access journals guide.

⏱️What is the average review time?

Initial decisions take 4-6 weeks, with total time to publication around 8-12 weeks. Track your academic progress with our academic calendar.

πŸ“Where is the submission portal for the New England Journal of Medicine?

Submissions go through the Editorial Manager at the author center. For preparation, see publishing resources.

πŸ“šWhich databases index the New England Journal of Medicine?

It is indexed in PubMed, Scopus, Web of Science, and Embase. Enhance your research visibility; explore research grants database for funding.

πŸ‘¨β€βš•οΈWho is the Editor-in-Chief?

Eric J. Rubin, MD, PhD, leads the team. Connect with experts via Rate My Professor for insights.

πŸš€What career value does publishing here provide?

A publication boosts CVs for tenure and grants. Find related positions at tenure-track faculty jobs.

βš–οΈHow does it compare to peer journals like The Lancet?

With a 96.2 impact factor, it excels in clinical focus versus The Lancet's policy emphasis. See comparisons in our career advice for academia.
Β